baber/WOPTO huggingface dataset:
Patent CA-2687925-A1 (CA)
Inventor: SGARIGLIA JEAN
IPC: E04H17/26
Filed: 2009-12-23
Abstract: There is provided an extendable baluster assembly for use with a handrail, the extendable baluster assembly comprising a baluster comprising an inner member and an outer member circumscribing a portion of the inner member in a telescopic relation, the outer member being fixable to the inner member; and a railing connector having a tubular body defining a cavity for receiving a top end of the baluster. There is also provided an extendable baluster assembly for use with a handrail, the extendable baluster assembly comprising a telescopic baluster; a ground connector adapted to be attached to a ground surface; a railing connector adapted to be attached to a handrail; and rotational joints between the baluster and the railing connector, and between the baluster and the ground connector, whereby the baluster is rotatable.
Patent CA-2687936-A1 (CA)
Inventor: BEAUPRE RICHARD ALFRED
IPC: F28F3/12
Filed: 2009-12-10
Abstract: A cooling device (10) includes a ceramic substrate (16) with a metal layer (22) bonded to an outer planar surface (18). The cooling device (10) also includes a channel layer (24) bonded to an opposite side of the ceramic substrate (16) and a manifold layer (26) bonded to an outer surface (28) of the channel layer (24).  The substrate layers (16), (22), (24), (26) are bonded together using a high temperature process such as brazing to form a single substrate assembly (14). A plenum housing (30) is bonded to the single substrate assembly (14) via a low temperature bonding process such as adhesive bonding and is configured to provide extended manifold layer inlet and outlet ports (32), (34).
Patent CA-2689080-A1 (CA)
Title: Treating benign prostate hyperplasia with sarms
Inventor: STEINER MITCHELL S
IPC: A61K31/00
Filed: 2003-02-06
Abstract: This invention provides a method of treating, preventing, suppressing, inhibiting or reducing the incidence of benign prostate hyperplasia in a male subject, by administering to the subject a selective androgen receptor modulator (SARM) and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, or any combination thereof as described herein. This invention also provides a method of treating a subject suffering from hair loss, comprising the step of administering to the subject a therapeutically effective amount of a 5-a reductase enzyme type 1 and /or type 2 inhibitor, wherein said inhibitor is a selective androgen receptor modulator (SARM) and/or its analog, derivative, isomer, metabolite,pharmaceutically acceptable salt, pharmaceutical product, hydrate, Woxide, or any combination thereof as described herein.;  This invention also provides a method of inhibiting a 5-a reductase type 1 and/or type 2 enzyme, comprising contacting the enzyme with an effective 5-a reductase inhibitory amount of a selective androgen receptor modulator (SARM) and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, or any combination thereof, as described herein.
Patent CA-2690651-A1 (CA)
Inventor: FERNANDO M ROHAN
IPC: C12N15/10
Filed: 2010-01-21
Abstract: A method for preserving and processing fetal nucleic acids located within maternal plasma is disclosed, wherein a sample of maternal blood containing fetal nucleic acids is treated to reduce both cell lysis of the maternal blood cells and deoxyribonuclease (DNase) and ribonuclease (RNase) activity within the fetal nucleic acids. The treatment of the sample aids in increasing the amount of fetal nucleic acids that can be identified and tested while maintaining the structure and integrity of the fetal nucleic acids.
Patent CA-2691412-A1 (CA)
Inventor: LEFRANC OLIVIER
IPC: A61L31/12
Filed: 2008-06-26
Abstract: A mesh implant is disclosed which may be utilized for treating urinary incontinence, hernias, uterovaginal prolapses and other related injuries.
Patent CA-2692153-A1 (CA)
Inventor: STANTON MATTHEW G
IPC: A61K31/5377
Filed: 2008-06-24
Abstract: The present invention relates to a novel class of pyridyl and pyrimidinyl derivatives. The pyridyl and pyrimidinyl compounds can be used to treat cancer. The pyridyl and pyrimidinyl compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases. The present invention further provides pharmaceutical compositions comprising the pyridyl and pyrimidinyl derivatives and safe dosing regimens of these pharmaceutical compositions, which are easy to follow, and which result in a therapeutically effective amount of the pyridyl and pyrimidinyl derivatives in vivo.
Patent CA-2692992-A1 (CA)
Inventor: YERMOLENKO DMYTRO
IPC: G07D7/00
Filed: 2010-02-11
Abstract: A variable length banknote drive path is advantageously used to provide a continuous drive path between components of an automated payment system. The banknote drive path includes at least a first inlet/outlet for receiving or outputting banknotes from the payment system and a movable second inlet/outlet for connecting with components provided along the drive path. With this arrangement the second inlet/outlet moves to provide a continuous drive path between components exchanging banknotes.
Patent CA-2694504-A1 (CA)
Title: (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
Inventor: BENCHERIF MEROUANE
IPC: A61P29/00
Filed: 2008-08-01
Abstract: The present invention relates to (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems.
Patent CA-2695436-A1 (CA)
Inventor: SUGAHARA KAYTARO GEORGE
IPC: H04N7/14
Filed: 2008-08-08
Abstract: Methods are provided for providing information to a viewer of a digital broadcast. Digital broadcasts which include audio components, video components, and an additional information component are transmitted to media content display devices.  Information may be extracted from the information component via user activation of an information interface and selection of desired information. The desired information may be extracted from the information component of the digital broadcast and/or transmitted to a broadcaster who may then, upon receipt of the request for information, modify the information component of the digital broadcast to the viewer.
Patent CA-2697280-A1 (CA)
Inventor: KIEST LARRY W
IPC: F16L55/179
Filed: 2008-08-22
Abstract: A liner tube (38, 40) (74) is provided for repairing either a single pipe line (70) or a main pipe line (50) having a lateral pipe line (52) connected thereto. The liner tube assembly includes a liner tube (38, 40) (74) impregnated with a liquid material capable of curing and hardening. The liner tube (38, 40) (74) includes a gasket (56) or band (62) positioned about the juncture of the pipe lines (50, 52). The gasket (56) or bands (62) (76) (78) form a tight seal between the liner tube (38) (40) (74) and the pipe line.
Patent CA-2702398-A1 (CA)
Inventor: HARPER DAVID A
IPC: E04H15/54
Filed: 2008-10-10
Abstract: A tent having an automatically stored window covering.  As a window for the tent is moved from a closed position, where a fabric cover covers the window opening, to an open position, where the fabric cover is partially or fully removed from the opening, the fabric cover automatically stores itself. The only use effort to both open and store the fabric cover is in opening the fabric cover.
Patent CA-2703964-A1 (CA)
Inventor: CALDWELL CRAIG
IPC: B65D47/08
Filed: 2008-10-23
Abstract: A container assembly (10) includes a container having an unthreaded finish portion (18) and a closure (28) having a downwardly depending sidewall (38) and blocking structure (40) provided at a lowerend of the sidewall for securing the closure on to the unthreaded finish portion. The sidewall is provided with a predetermined area of weakness (48) so that in the event that an attempt is made to remove the closure from the container the predetermined area of weakness will rupture, leaving the closure with insufficient structural integrity to be successfully reapplied to the container. The container assembly has particular utility for use in packaging brand-name comestibles such as ketchup for restaurant use. It will frustrate efforts by the restaurant to replenish the brand-name comestible with a cheaper replacement within a dispensing container that is still labeled with the brand of the original product.
Patent CA-2704108-A1 (CA)
Inventor: STEINKELLNER HERTA
IPC: C12N9/10
Filed: 2007-10-31
Abstract: Provided is a novel method to produce a plant cell or plant having an altered N-glycosylation pattern resulting, in particular, in a low level of .beta.-1,2-xylose residues and core .alpha.-1,3-fucose residues on protein-bound N -glycans. Said plant cell or plant is of particular interest for producing therapeutic glycoproteins with a low, or not detectable, level of .beta.-1,2-xylose and .alpha.-1,3-fucose residues. Also provided are novel .alpha.-1,3-fucosyltransferase nucleotide sequences and uses thereof.
Patent CA-2706776-A1 (CA)
Inventor: HUSSAIN SAADAT
IPC: C07C41/22
Filed: 2008-11-24
Abstract: Processes for preparing brominated aromatic flame retardant having a reduced content of occluded free bromine are described. The processes comprise subdividing, during bromination of an aromatic compound, solid particles that form in a bromination reaction mixture in which an excess of liquid bromine and a Lewis acid bromination catalyst are present, said subdividing taking place within the confines of said reaction mixture. Subdivision is effected by grinding, milling, or sonication.
Patent CA-2707096-A1 (CA)
Inventor: ARMBRUSTER FRANZ PAUL
IPC: A61K38/08
Filed: 2008-12-01
Abstract: Composition for treatment and prevention of human hair loss and/or hair greying, comprising an effective amount of thymic peptides of the family thymulin, thymosin alpha-1 and thymosin beta-4 and pharmaceutical excipient, diluent or carrier. Method and pharmaceutical composition for treatment and prevention of balding, hair loss, and alopecia.
Patent CA-2708204-A1 (CA)
Inventor: GRENIER GILLES
IPC: E04G21/14
Filed: 2010-06-21
Abstract: A staircase of skeletal form is prefabricated and is provided with prefabricated decorative cladding finishing plates for the treads, the risers and the stringer boards, the plates being pre-drilled for ease of assembly, a plurality of finishing plates can be preassembled, or factory assembled, together before installation over a portion of the prefabricated staircase, and the installation method thereof.
Patent CA-2708691-A1 (CA)
Title: Hygiene compliance monitoring system
Inventor: WEGELIN JACKSON W
IPC: A47K1/00
Filed: 2010-06-29
Abstract: A hygiene compliance monitoring system provides a dispenser that is associated with a data collection unit that collects dispensing events, such as the dispensement of material from the dispenser, which occurs during time segments of a predetermined duration. The hygiene event monitoring system also includes a portable data acquisition unit that is in wireless communication with the data collection unit of the dispenser. As such, when the data acquisition unit is brought within the range of reception of the data collection unit, the hygiene compliance data and time segment information are transmitted to the data acquisition unit and stored at a portable memory unit, which is removable. As such, the hygiene compliance data stored on the portable memory unit can be readily transferred to any desired computing device for analysis and report generation.
Patent CA-2712909-A1 (CA)
Title: Method and apparatus for normalizing performance of an electron source
Inventor: QUARMBY SCOTT T
IPC: B01D59/44
Filed: 2009-02-03
Abstract: A method for operating a mass spectrometer includes determining a first performance characteristic while operating the mass spectrometer with a first electron emitter, storing first information relating to the first performance characteristic, determining a second performance characteristic while operating the mass spectrometer with a second electron emitter, storing second information relating to the second performance characteristic, and thereafter switching from operation using the first electron emitter to operation using the second electron emitter. The switching includes using the first and second information to normalize performance of the second electron emitter after the switching relative to performance of the first electron emitter before the switching.
Patent CA-2718644-A1 (CA)
Inventor: PARKVALL STEFAN
IPC: H04B7/005
Filed: 2008-06-25
Abstract: A method (200) for use in a wireless cellular access system (100), according to which users (120) in a cell (110) in the system (100) receive one or more transmission power control commands on a control channel (205), the transmission power control commands comprising (225) an identifier for the intended user or users, said identifier being either an identifier for a specific user (230) or for a group of users (235). A user disregards (240) one or more predefined control commands if the identifier of the control command is for a group of users in which said user is included.
Patent CA-2719891-A1 (CA)
Inventor: TYSOWSKI PIOTR KONRAD
IPC: H04W4/50
Filed: 2010-11-03
Abstract: La révélation porte sur une méthode (100), un produit de programme informatique, un appareil mobile (210) permettant de configurer un service (160) accessible à l'aide de l'appareil mobile (210). L'appareil mobile (210) est configuré pour permettre une détermination de ses données de localisation (110) à l'aide d'une ou de plusieurs d'une pluralité de techniques de localisation. La configuration du service (160) comprend l'obtention (130) d'information de qualité (140) comprenant une désignation de la technique de localisation utilisée pour déterminer lesdites données de localisation (110) et au moins partiellement une qualité desdites données de localisation (110), et l'intégration (150) de ladite information de qualité (140) au moins partiellement audit service (160) pour permettre une modification (155) dudit service (160) fondée sur ladite information de qualité (140). Divers exemples de services (160) activés ou améliorés par cette capacité sont décrits, y compris le service de caméra, les services de navigation, les services de partage de données. Diverses configurations de produits de programme informatique, appareils mobiles et systèmes permettant les services mentionnés sont également décrits.
Patent CA-2722691-A1 (CA)
Inventor: ZHANG HAIHONG
IPC: A61B5/374
Filed: 2008-04-28
Abstract: A method and system for concentration detection. The method for concentration detection comprises the steps of extracting temporal features from brain signals; classifying the extracted temporal features using a classifier to give a score x1;  extracting spectral-spatial features from brain signals; selecting spectral-spatial features containing discriminative information between concentration and non-concentration states from the set of extracted spectral-spatial features; classifying the selected spectral-spatial features using a classifier to give a score x2; combining the scores x1 and x2 to give a single score and determining if the subject is in a concentration state based on the single score.
Patent CA-2724154-A1 (CA)
Inventor: LALONDE JEAN-PIERRE
IPC: A61B18/02
Filed: 2009-05-14
Abstract: The present invention provides a medical system, including a catheter defining an injection lumen, a chamber in fluid communication with the injection lumen, and an exhaust lumen in fluid communication with the chamber; a first temperature sensor positioned in the exhaust lumen proximal to the chamber; a second temperature sensor positioned in the chamber;  and a console in electrical communication with the first and second temperature sensors, the controller modifying coolant flow through the medical device based at least in part upon a signal received from the first and second temperature sensor. The system may further include a thermally-conductive element circumscribing a substantial portion of the exhaust lumen proximal to the chamber, where the first temperature sensor is mounted to the thermally-conductive element, and the thermally-conductive element may include at least one of a braid, coil, and band.
Patent CA-2726616-A1 (CA)
Inventor: CAMPINS INMACULADA
IPC: A61K9/08
Filed: 2009-05-29
Abstract: Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions.
Patent CA-2728319-A1 (CA)
Title: Separation media slurry tank
Inventor: LONNQVIST TOM
IPC: B01D15/20
Filed: 2009-06-04
Abstract: A method for handling separation media slurry in a tank, before transferring the separation media slurry to a column or a container. The method comprises the steps of: - blowing gas from the bottom of the tank into the sedimented media in the tank and thereby the sedimented media starts to re-suspend; - starting an impeller (7) provided in the tank in order to stir said media slurry that already has started to re-suspend.
Patent CA-2729057-A1 (CA)
Inventor: THEDE KAI
IPC: A61K31/40
Filed: 2009-06-18
Abstract: The present application relates to novel 3-cyanoalkyl- and 3-hydroxyalkyl-substituted indole derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of cardiovascular diseases.
Patent CA-2729292-A1 (CA)
Title: Phenoxyphenyl sulfide, sulfinyl and sulfonyl antagonists of prostaglandin d2 receptors
Inventor: HUTCHINSON JOHN HOWARD
IPC: A61K31/192
Filed: 2009-07-02
Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
Patent CA-2732705-A1 (CA)
Inventor: LIN CHANG-CHEN
IPC: A47C3/03
Filed: 2011-02-23
Abstract: A rocking chair includes a fixed base having a base portion located on the ground. The base portion includes front and rear sides spaced in a rocking direction. A  connecting frame extends upright from the base portion and has a receiving space receiving a rocking mechanism. The rocking mechanism includes a bottom plate, a strut, and front and rear rocking members. The strut extends upright from the bottom plate and is fixed to a seat. Upper ends of the front and rear rocking members are pivotably connected to the connecting frame. Lower ends of the front and rear rocking members are pivotably connected to front and rear ends of the bottom plate. The rocking mechanism is rockable in the receiving space in the rocking direction relative to the fixed base. A positioning mechanism controls the rocking mechanism to be in a rockable state or a positioned state.
Patent CA-2736004-A1 (CA)
Inventor: STEPNIAK FRANK
IPC: H01R4/16
Filed: 2005-06-01
Abstract: An apparatus and method of operation are disclosed for a high current electrical connector system and switch. In operation there is provided a method of reducing bending forces on an electrical connection point wherein a first contact is electrically connected to a second contact by a rigid electrical connection. A mechanically weakened portion on the first contact is provided and the bend forces are allowed to bend the first contact at the mechanically weakened portion, thereby reducing the bending forces applied to the electrical connection point.
Patent CA-2740988-A1 (CA)
Inventor: SHANKS MARK
IPC: H01J1/62
Filed: 2009-10-16
Abstract: A transparent directional polar-ized light-emitting device includes a transpar-ent anode and a transparent cathode, a radia-tion-emitting layer between the anode and the cathode, an optically active reflective layer with a reflection band that matches a chirality and at least partially encompasses a wave-length band of radiation emitted from the radi-ation-emitting layer, the optically active light blocking layer located on a side of the radia-tion-emitting layer, and a transparent substrate adjacent to the optically active reflective layer.
Patent CA-2741087-A1 (CA)
Inventor: PENA CAROL E A
IPC: C12Q1/68
Filed: 2009-10-21
Abstract: The present invention relates to, for example, (1) a novel method for identification of clinically useful serum and/or tumor biomarkers and expression signatures that can be used for detection, prognostication and guidance for the treatment of patients with hepatocellular carcinoma (HCC); and (2) discovery of an expression signature that can be used to monitor and/or study the efficacy of a chemotherapeutic regimen, such as, for example, sorafenib (solely or in combination with other agents).  The present invention also provides a method for predicting clinical outcomes, such as, for example, overall survival (OS), time to progression (TTP) and/or likelihood of benefitting from a chemotherapeutic treatment (i.e., sorafenib) in HCC patients based on the analysis of such biomarkers.
Patent CA-2742001-A1 (CA)
Inventor: LI XIN
IPC: G05F1/00
Filed: 2009-05-07
Abstract: Embodiments provide a Magnetic Resonance Imaging (MRI) technique and optionally software - collectively referred to as the "shutter-speed" model - to analyze image data of cancer patients.  Embodiments provide a minimally invasive, yet precisely accurate, approach to determining whether tumors are malignant or benign by distinguishing the characteristics of contrast reagent activity in benign and malignant tumors. Exemplary embodiments provide MRI measured biomarkers for tumor malignancy determination, effectively eliminating or limiting the false positives suffered by existing MRI techniques.
Patent CA-2743264-A1 (CA)
Inventor: CLAY JULIA MARIE
IPC: A61K31/501
Filed: 2009-11-09
Abstract: The present invention provides novel tetrasubstituted pyridazine hedgehog pathway antagonists useful in the treat-ment of cancer.
Patent CA-2743746-A1 (CA)
Inventor: STEELBERG RYAN
IPC: G06Q30/00
Filed: 2009-11-12
Abstract: An engine, system and method for selecting at least one endorser for use in one or more advertisements. The engine, system and method may include a talent library including a plurality of electronic media assets delineated by respective ones of the at least one endorser, a mention tracker that electronically tracks mentions of the media assets, and that assigns at least one metric to each of the mentions, and a graphical user display that displays the metrics correspondent to a selected one of the at least one endorser based on ones selected from a plurality of geographies, wherein the selected ones of the geographies are a situs of ones of the mentions.